IRD: Opus Genetics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 31.57
Enterprise Value ($M) -5.06
Book Value ($M) 34.30
Book Value / Share 1.09
Price / Book 0.92
NCAV ($M) 34.30
NCAV / Share 1.09
Price / NCAV 0.92

Profitability (mra)
Return on Invested Capital (ROIC) -0.79
Return on Assets (ROA) -0.50
Return on Equity (ROE) -0.54

Liquidity (mrq)
Quick Ratio 6.63
Current Ratio 6.63

Balance Sheet (mrq) ($M)
Current Assets 40.39
Assets 40.39
Liabilities 6.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
10-29 13D Foundation Fighting Blindness Retinal Degeneration Fund 8.16

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2024 ☐ TRANSITION REPORT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 16,551 47,151 35.10
2025-03-06 18,062 62,285 29.00
2025-03-05 25,292 111,761 22.63
2025-03-04 63,995 137,854 46.42

(click for more detail)

Similar Companies
INO – Inovio Pharmaceuticals, Inc. INTS – Intensity Therapeutics, Inc.
IPA – ImmunoPrecise Antibodies Ltd. ITRM – Iterum Therapeutics plc
JAGX – Jaguar Health, Inc.


Financial data and stock pages provided by
Fintel.io